Bioorganic & Medicinal Chemistry Letters | Vol 25, Issue 7, Pages 1357-1654 (1 April 2015) | ScienceDirect.com by Elsevier
Figure 3, Summary of second generation small molecule 3CLpro inhibitors, some containing reactive warhead groups and known to have a covalent mode of action - Probe Reports from the NIH Molecular Libraries
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
名古屋大学大学院創薬科学研究科 天然物化学分野
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
CCHF | Publication
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
Dima Sabbah, Ph.D. PEER REVIEWED SCIENTIFIC ARTICLES (11SUBMITTED/ ACCEPTED/ PUBLISHED PEER REVIEWED ARTICLES) 1. Sweidan K.,
Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture
Bioorganic & Medicinal Chemistry Letters | Vol 23, Issue 1, Pages 1-382 (1 January 2013) | ScienceDirect.com by Elsevier
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Portfolio of hits — Laboratory of Medicinal Chemistry — Ghent University
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 | ACS Medicinal Chemistry Letters
![PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]](https://i1.rgstatic.net/publication/318331613_Corrigendum_to_Synthesis_and_carbonic_anhydrase_inhibitory_properties_of_novel_chalcone_substituted_benzenesulfonamides_Bioorg_Med_Chem_Lett_26_2016_5867-5870/links/5e28005b92851c3aadcfb95e/largepreview.png "PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]")
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]
Bioorganic
成果及论文 - 南华大学王震课题组
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
Publications_2012
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758 (15 March 2006) | ScienceDirect.com by Elsevier
The Dark Side of Fluorine | ACS Medicinal Chemistry Letters
